ICYMI: Innovative payment models helping provide patient access to new medicines

As we continue to make remarkable strides to treat our most costly and challenging diseases, there is a renewed focus on ensuring patients have access to the most innovative medicines. Increasingly, biopharmaceutical companies are entering into value-based contracts with payers  – such as payment models that link reimbursement to patient outcomes. By doing so, payers and biopharmaceutical companies are working together to control costs and provide patients access to new, life-saving treatments. 
Source: The Catalyst - Category: Pharmaceuticals Tags: The Value Collaborative Source Type: news